Clinical trial
A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies
NCT04172597
Study timeline
Study start (actual)2019-12-23Date precision: day
Registry last updated2024-03-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Colorectal Cancerunresolved
Solid Tumorunresolved
Glioblastome Multiformeunresolved
Interventions
LoperamideDRUG · verified · RxNorm: loperamide
Sponsors & collaborators
Spectrum Pharmaceuticals, Inclead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04172597 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.